Compare VOR & UFCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VOR | UFCS |
|---|---|---|
| Founded | 2015 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | 2021 | 1995 |
| Metric | VOR | UFCS |
|---|---|---|
| Price | $22.53 | $53.87 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 2 |
| Target Price | ★ $45.33 | $40.50 |
| AVG Volume (30 Days) | ★ 754.9K | 112.5K |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 2.01% |
| EPS Growth | N/A | ★ 87.45 |
| EPS | N/A | ★ 2.45 |
| Revenue | N/A | ★ $1,386,412,000.00 |
| Revenue This Year | N/A | $11.80 |
| Revenue Next Year | N/A | $8.77 |
| P/E Ratio | ★ N/A | $21.99 |
| Revenue Growth | N/A | ★ 10.62 |
| 52 Week Low | $1.90 | $29.75 |
| 52 Week High | $49.95 | $55.82 |
| Indicator | VOR | UFCS |
|---|---|---|
| Relative Strength Index (RSI) | 55.02 | 58.42 |
| Support Level | $21.75 | $52.01 |
| Resistance Level | $24.44 | $55.82 |
| Average True Range (ATR) | 1.05 | 1.34 |
| MACD | -0.19 | -0.05 |
| Stochastic Oscillator | 41.40 | 75.24 |
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.
United Fire Group Inc is engaged in the business of writing property and casualty insurance and selling annuities through a network of independent agencies. The company's only operating segment is property and casualty insurance, which includes commercial lines insurance, personal lines insurance, and assumed reinsurance. The primary source of revenue is premium and investment income.